Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy: The ReCONSIDER Study. A Two-step, Multifactorial, Electrophysiology-inclusive Approach

NCT04246450 is registered in ClinicalTrials.gov with University of Athens as lead sponsor.

NCT NCT04246450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04246450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy: The ReCONSIDER Study. A Two-step, Multifactorial, Electrophysiology-inclusive Approach
Lead sponsor
University of Athens
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2020
Completion date
May 1, 2025
Enrollment
675 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dilated cardiomyopathy, sudden cardiac death due to cardiac arrhythmia